IP Library Granted Patent US 8,871,785
Granted Patent B2
US 8,871,785 · App. 13/848,593 · Granted Oct 28, 2014

Antiviral phosphonate analogs

Inventors: Constantine G. Boojamra (San Francisco, CA); Carina E. Cannizzaro (Foster City, CA); James M. Chen (San Ramon, CA); Xiaowu Chen (Hillsborough, CA); Aesop Cho (Mountain View, CA); Lee S. Chong (Newark, CA); Maria Fardis (San Carlos, CA); Haolun Jin (Foster City, CA); Ralph Hirschmann (Lansdale, PA); Alan X. Huang (San Mateo, CA); Choung U. Kim (San Carlos, CA); Thorsten A. Kirschberg (Redwood City, CA); Christopher P. Lee (San Francisco, CA); William A. Lee (Los Altos, CA); Richard L. Mackman (Millbrae, CA); David Y. Markevitch (Los Angeles, CA); David A. Oare (Belmont, CA); Vidya K. Prasad (Munich, DE); Hyung-Jung Pyun (Fremont, CA); Adrian S. Ray (Redwood City, CA); Rosemarie O'Shea (San Carlos, CA); Sundaramoorthi Swaninathan (Burlingame, CA); William J. Watkins (Saratoga, CA); Jennifer R. Zhang (Union City, CA)
Assignee: Gilead Sciences, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,871,785
App. No.
13/848,593
Granted
Oct 28, 2014
Kind
B2
Abstract

The invention is related to phosphorus substituted compounds with antiviral activity, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

Claims (43)

1. A conjugate of the following formula:

or a pharmaceutically acceptable salt or solvate thereof;

wherein:

B is selected from adenine, guanine, cytosine, uracil, thymine, 7-deazaadenine, 7-deazaguanine, 7-deaza-8-azaguanine, 7-deaza-8-azaadenine, inosine, nebularine, nitropyrrole, nitroindole, 2-aminopurine, 2-amino-6-chloropurine, 2,6-diaminopurine, hypoxanthine, pseudouridine, pseudocytosine, pseudoisocytosine, 5-propynylcytosine, isocytosine, isoguanine, 7-deazaguanine, 2-thiopyrimidine, 6-thioguanine, 4-thiothymine, 4-thiouracil, O 6 -methylguanine, N 6 -methyladenine, O 4 -methylthymine, 5,6-dihydrothymine, 5,6-dihydrouracil, 4-methylindole, substituted triazole, and pyrazolo[3,4-d]pyrimidine;

X is selected from O, C(R y ) 2 , OC(R y ) 2 , NR and S;

Z is independently selected from H, OH, OR, NR 2 , CN, NO 2 , SH, SR, F, Cl, Br, and I;

Y 1 is independently O, S, NR, + N(O)(R), N(OR), + N(O)(OR), or N—NR 2 ;

Y 2 of the moiety

is independently CR 2 , NR, + N(O)(R), N(OR), + N(O)(OR), N—NR 2 , S, S—S, S(O), or S(O) 2 ;

Y 2 of the moiety

is independently O, CR 2 , NR, + N(O)(R), N(OR), + N(O)(OR), N—NR 2 , S, S—S, S(O), or S(O) 2 ;

M2 is 0, 1 or 2;

R y is independently H, F, Cl, Br, I, OH, —C(═Y 1 )R, —C(═Y 1 )OR, —C(═Y 1 )N(R) 2 , —N(R) 2 , — + N(R) 3 , —SR, —S(O)R, —S(O) 2 R, —S(O)(OR), —S(O) 2 (OR), —OC(═Y 1 )R, —OC(═Y 1 )OR, —OC(═Y 1 )(N(R) 2 ), —SC(═Y 1 )R, —SC(═Y 1 )OR, —SC(═Y 1 )(N(R) 2 ), —N(R)C(═Y 1 )R, N(R)C(═Y 1 )OR, or —N(R)C(═Y 1 )N(R) 2 , amino (—NH 2 ), ammonium (—NH 3 + ), alkylamino, dialkylamino, trialkylammonium, C 1 -C 8 alkyl, C 1 -C 8 alkylhalide, carboxylate, sulfate, sulfamate, sulfonate, 5-7 membered ring sultam, C 1 -C 8 alkylsulfonate, C 1 -C 8 alkylamino, 4-dialkylaminopyridinium, C 1 -C 8 alkylhydroxyl, C 1 -C 8 alkylthiol, alkylsulfone (—SO 2 R), arylsulfone (—SO 2 Ar), arylsulfoxide (—SOAr), arylthio (—SAr), sulfonamide (—SO 2 NR 2 ), alkylsulfoxide (—SOR), ester (—C(═O)OR), amido (—C(═O)NR 2 ), 5-7 membered ring lactam, 5-7 membered ring lactone, nitrite (—CN), azido (—N 3 ), nitro (—NO 2 ), C 1 -C 8 alkoxy (—OR), C 1 -C 8 alkyl, C 1 -C 8 substituted alkyl, C 1 -C 8 alkenyl, C 1 -C 8 substituted alkenyl, C 1 -C 8 alkynyl, C 1 -C 8 substituted alkynyl, C 6 -C 20 aryl, C 6 -C 20 substituted aryl, C 2 -C 20 heterocycle, C 2 -C 20 substituted heterocycle, polyethyleneoxy, or W 3 ; or when taken together, R y forms a carbocyclic ring of 3 to 7 carbon atoms;

R x is independently R y , a protecting group, or the formula:

wherein:

M1a, M1c, and M1d are independently 0 or 1;

M12c is 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12; and

R is C 1 -C 8 alkyl, C 1 -C 8 substituted alkyl, C 1 -C 8 alkenyl, C 1 -C 8 substituted alkenyl, C 1 -C 8 alkynyl, C 1 -C 8 substituted alkynyl, C 6 -C 20 aryl, C 6 -C 20 substituted aryl, C 2 -C 20 heterocycle, C 2 -C 20 substituted heterocycle, or a protecting group; and

W 3 is W 4 or W 5 , where W 4 is R, —C(Y 1 )R y , —C(Y 1 )W 5 , —SO 2 R y , or —SO 2 W 5 ; and W 5 is a carbocycle or a heterocycle wherein W 5 is independently substituted with 0 to 3 R y groups.

2. The conjugate of claim 1 wherein C 1 -C 8 substituted alkyl, C 1 -C 8 substituted alkenyl, C 1 -C 8 substituted alkynyl, C 6 -C 20 substituted aryl, and C 2 -C 20 substituted heterocycle are independently substituted with one or more substituents selected from F, Cl, Br, I, OH, —NH 2 , —NH 3 + , —NHR, —NR 2 , —NR 3 + , C 1 -C 8 alkylhalide, carboxylate, sulfate, sulfamate, sulfonate, 5-7 membered ring sultam, C 1 -C 8 alkylsulfonate, C 1 -C 8 alkylamino, 4-dialkylaminopyridinium, C 1 -C 8 alkylhydroxyl, C 1 -C 8 alkylthiol, —SO 2 R, —SO 2 Ar, —SOAr, —SAr, —SO 2 NR 2 , —SOR, —CO 2 R, —C(═O)NR 2 , 5-7 membered ring lactam, 5-7 membered ring lactone, —CN, —N 3 , —NO 2 , C 1 -C 8 alkoxy, C 1 -C 8 trifluoroalkyl, C 1 -C 8 alkyl, C 3 -C 12 carbocycle, C 6 -C 20 aryl, C 2 -C 20 heterocycle, polyethyleneoxy, phosphonate, phosphate, and a prodrug moiety.

3. The conjugate of claim 1 wherein protecting group is selected from a carboxyl ester, a carboxamide, an aryl ether, an alkyl ether, a trialkylsilyl ether, a sulfonic acid ester, a carbonate, and a carbamate.

4. The conjugate of claim 1 wherein W 5 is selected from the structures:

5. The conjugate of claim 1 wherein X is O and each R y is H.

6. The conjugate of claim 1 wherein the conjugate is a resolved enantiomer having the structure:

7. The conjugate of claim 1 wherein the conjugate is a resolved enantiomer having the structure:

8. The conjugate of claim 1 having the structure:

9. The conjugate of claim 1 having the structure:

10. The conjugate of claim 1 having the structure:

11. The conjugate of claim 1 having the structure:

12. The conjugate of claim 1 having the structure:

wherein R 2 is H or C 1 -C 8 alkyl.

13. The conjugate of claim 1 having the structure:

14. The conjugate of claim 13 wherein Z is H.

15. The conjugate of claim 13 wherein B is adenine.

16. The conjugate of claim 13 having the structure:

wherein Y 2c is O, N(R y ) or S.

17. The conjugate of claim 16 having the structure:

18. The conjugate of claim 17 wherein Y 2c is O.

19. The conjugate of claim 17 wherein Y 2c is N(CH 3 ).

20. The conjugate of claim 1 wherein substituted triazole has the structure:

21. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a conjugate as described in claim 1 , or a pharmaceutically acceptable salt or solvate thereof.

22. A method for promoting an anti-viral effect in vitro or in vivo comprising contacting a sample in need of such treatment with a a conjugate as described in claim 1 , or a pharmaceutically acceptable salt or solvate thereof.

23. A method of inhibiting a viral infection in an animal, comprising administering an effective amount of a conjugate as described in claim 1 , or a pharmaceutically acceptable salt or solvate thereof, to the animal.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 8, 2014
From: BOOJAMRA, CONSTANTINE G.; CANNIZZARO, CARINA; CHEN, JAMES M.; CHEN, XIAOWU; CHO, AESOP; CHONG, LEE S.; FARDIS, MARIA; JIN, HAOLUN; HIRSCHMANN, RALPH F.; HUANG, ALAN X.; KIM, CHOUNG U.; KIRSCHBERG, THORSTEN; LEE, CHRISTOPHER P.; LEE, WILLIAM A.; MACKMAN, RICHARD L.; MARKEVITCH, DAVID Y.; OARE, DAVID A.; PRASAD, VIDYA K.; PYUN, HYUNG-JUNG; RAY, ADRIAN S.; SHERLOCK, ROSEMARIE; SWAMINATHAN, SUNDARAMOORTHI; WATKINS, WILLIAM J.; ZHANG, JENNIFER R.
To: GILEAD SCIENCES, INC.
Reel/Frame 031915/0287 →
Continuity (95)
Continuation 13187293 · Jul 20, 2011
Division 12166076 · Jul 1, 2008
Division 10832815 · Apr 26, 2004
Provisional Application 60465630 · Apr 25, 2003
Provisional Application 60465400 · Apr 25, 2003
Provisional Application 60465587 · Apr 25, 2003
Provisional Application 60465463 · Apr 25, 2003
Provisional Application 60465602 · Apr 25, 2003
Provisional Application 60465598 · Apr 25, 2003
Provisional Application 60465633 · Apr 25, 2003
Provisional Application 60465550 · Apr 25, 2003
Provisional Application 60465610 · Apr 25, 2003
Provisional Application 60465720 · Apr 25, 2003
Provisional Application 60465634 · Apr 25, 2003
Provisional Application 60465537 · Apr 25, 2003
Provisional Application 60465698 · Apr 25, 2003
Provisional Application 60465667 · Apr 25, 2003
Provisional Application 60465554 · Apr 25, 2003
Provisional Application 60465553 · Apr 25, 2003
Provisional Application 60465561 · Apr 25, 2003
Provisional Application 60465548 · Apr 25, 2003
Provisional Application 60465696 · Apr 25, 2003
Provisional Application 60465347 · Apr 25, 2003
Provisional Application 60465289 · Apr 25, 2003
Provisional Application 60465478 · Apr 25, 2003
Provisional Application 60465600 · Apr 25, 2003
Provisional Application 60465591 · Apr 25, 2003
Provisional Application 60465684 · Apr 25, 2003
Provisional Application 60465821 · Apr 25, 2003
Provisional Application 60465647 · Apr 25, 2003
Provisional Application 60465742 · Apr 25, 2003
Provisional Application 60465649 · Apr 25, 2003
Provisional Application 60465690 · Apr 25, 2003
Provisional Application 60465469 · Apr 25, 2003
Provisional Application 60465408 · Apr 25, 2003
Provisional Application 60465608 · Apr 25, 2003
Provisional Application 60465584 · Apr 25, 2003
Provisional Application 60465687 · Apr 25, 2003
Provisional Application 60465759 · Apr 25, 2003
Provisional Application 60465559 · Apr 25, 2003
Provisional Application 60465322 · Apr 25, 2003
Provisional Application 60465377 · Apr 25, 2003
Provisional Application 60465844 · Apr 25, 2003
Provisional Application 60465544 · Apr 25, 2003
Provisional Application 60490799 · Jul 29, 2003
Provisional Application 60495687 · Aug 15, 2003
Provisional Application 60495490 · Aug 15, 2003
Provisional Application 60495805 · Aug 15, 2003
Provisional Application 60495684 · Aug 15, 2003
Provisional Application 60495600 · Aug 15, 2003
Provisional Application 60495342 · Aug 15, 2003
Provisional Application 60495564 · Aug 15, 2003
Provisional Application 60495772 · Aug 15, 2003
Provisional Application 60495592 · Aug 15, 2003
Provisional Application 60495453 · Aug 15, 2003
Provisional Application 60495491 · Aug 15, 2003
Provisional Application 60495964 · Aug 15, 2003
Provisional Application 60495317 · Aug 15, 2003
Provisional Application 60495696 · Aug 15, 2003
Provisional Application 60495760 · Aug 15, 2003
Provisional Application 60495334 · Aug 15, 2003
Provisional Application 60495671 · Aug 15, 2003
Provisional Application 60495349 · Aug 15, 2003
Provisional Application 60495273 · Aug 15, 2003
Provisional Application 60495763 · Aug 15, 2003
Provisional Application 60495345 · Aug 15, 2003
Provisional Application 60495602 · Aug 15, 2003
Provisional Application 60495343 · Aug 15, 2003
Provisional Application 60495344 · Aug 15, 2003
Provisional Application 60495278 · Aug 15, 2003
Provisional Application 60495277 · Aug 15, 2003
Provisional Application 60495275 · Aug 15, 2003
Provisional Application 60495630 · Aug 15, 2003
Provisional Application 60495485 · Aug 15, 2003
Provisional Application 60495430 · Aug 15, 2003
Provisional Application 60495388 · Aug 15, 2003
Provisional Application 60495341 · Aug 15, 2003
Provisional Application 60495631 · Aug 15, 2003
Provisional Application 60495633 · Aug 15, 2003
Provisional Application 60495632 · Aug 15, 2003
Provisional Application 60495539 · Aug 15, 2003
Provisional Application 60495387 · Aug 15, 2003
Provisional Application 60495392 · Aug 15, 2003
Provisional Application 60495425 · Aug 15, 2003
Provisional Application 60495393 · Aug 15, 2003
Provisional Application 60495616 · Aug 15, 2003
Provisional Application 60510245 · Oct 10, 2003
Provisional Application 60514202 · Oct 24, 2003
Provisional Application 60513948 · Oct 24, 2003
Provisional Application 60514258 · Oct 24, 2003
Provisional Application 60515266 · Oct 29, 2003
Provisional Application 60519476 · Nov 12, 2003
Provisional Application 60524340 · Nov 20, 2003
Provisional Application 60532591 · Dec 23, 2003
Related Publication 20130316969A1 · Nov 28, 2013